MAPT and Alzheimer disease: Through comprehensive qualitative and quantitative analysis of tau proteoforms from postmortem human brains involving 49 AD patients and 42 controls, researchers identified 95 unique PTMs across 88 amino acid residues, encompassing 55 phosphorylation, 17 ubiquitination, 19 acetylation, and four methylation sites.